Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
99 100 Next >
IceCure Medical Advances FDA Review
Via The Motley Fool
Tickers ICCM
Exposures Product Safety
Hyperfine Inc (NASDAQ:HYPR) Reports Mixed Q2 2025 Earnings: Revenue Misses but Margins Improve
Via Chartmill
Tickers HYPR
Exposures Product Safety
HeartBeam Inc (NASDAQ:BEAT) Reports Q2 2025 Results: Narrower Loss, FDA Progress, and Mixed Market Reaction
Via Chartmill
Tickers BEAT
Exposures Product Safety
Spectral Ai Posts 32% Revenue Drop in Q2
Via The Motley Fool
Tickers MDAI
Exposures Product Safety
IceCure (ICCM) Q2 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Tickers ICCM
Exposures Financial Product Safety
Levi & Korsinsky Reminds Capricor Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 15, 2025 - CAPR
Via NewMediaWire
Topics Fraud Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 22, 2025 in Replimune Group, Inc. Lawsuit - REPL
Via NewMediaWire
Topics Fraud Lawsuit
Tickers REPL
Exposures Financial Legal Product Safety
Levi &amp; Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 22, 2025 in Replimune Group, Inc. Lawsuit - REPL
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers REPL
Exposures Financial Legal Product Safety
Levi &amp; Korsinsky Reminds Capricor Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 15, 2025 - CAPR
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
From Novel Therapies To Treat Suicidal Bipolar Depression To Launching A Network Of Clinics, NRx Pharmaceuticals Is Getting Attention On Wall Street
Via NewMediaWire
Tickers NRXP
Exposures Product Safety
From Novel Therapies To Treat Suicidal Bipolar Depression To Launching A Network Of Clinics, NRx Pharmaceuticals Is Getting Attention On Wall Street
Via TheNewswire.com
Tickers NRXP
Exposures Product Safety
Cognition Therapeutics Surges 30% Pre-Market After FDA Backs Phase 3 Trial Design For Alzheimer's Drug
Via Benzinga
Tickers CGTX
Exposures Product Safety
A Non-Invasive Solution to a Confident Neckline: Botox for Platysmal Bands
Via 24-7 Press Release
Exposures Product Safety
Insmed Stock Closes At Nearly 25-Year High As Analysts Get Bullish On FDA Nod For Lung Disease Drug: Retail Traders Ecstatic
Via Stocktwits
Tickers BAC INSM RY TSX:RY WFC
Exposures Product Safety
The 5 Most Interesting Analyst Questions From Vertex Pharmaceuticals’s Q2 Earnings Call
Via StockStory
Topics Earnings Retirement
Exposures Financial Pension Product Safety
REGN Q2 Deep Dive: New Indications and Pipeline Progress Offset EYLEA Challenges
Via StockStory
Tickers REGN
Exposures Product Safety
Vicarious Surgical Narrows Loss in Q2
Via The Motley Fool
Topics Intellectual Property
Tickers RBOT
Exposures Intellectual Property Product Safety
NeuroPace (NPCE) Q2 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Tickers NPCE
Exposures Financial Product Safety
NeuroPace Reports Record Q2 Revenue
Via The Motley Fool
Tickers NPCE
Exposures Product Safety
Cue Biopharma Inc (NASDAQ:CUE) Q2 2025 Earnings: Revenue Surpasses Estimates, Loss Narrower Than Expected
Via Chartmill
Tickers CUE
Exposures Product Safety
ProKidney Corp (NASDAQ:PROK) Reports Mixed Q2 2025 Results with Regulatory Progress and Narrower Loss
Via Chartmill
Tickers PROK
Exposures Product Safety
SPECTRAL AI INC (NASDAQ:MDAI) Q2 2025 Earnings: Revenue Misses, Losses Widen Amid Regulatory Progress
Via Chartmill
Topics Artificial Intelligence
Tickers MDAI
Exposures Artificial Intelligence Product Safety
Levi & Korsinsky Notifies Capricor Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - CAPR
Via NewMediaWire
Topics Fraud Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
Replimune Group, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before September 22, 2025 to Discuss Your Rights - REPL
Via NewMediaWire
Topics Fraud Lawsuit
Tickers REPL
Exposures Financial Legal Product Safety
Levi &amp; Korsinsky Notifies Capricor Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - CAPR
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
Replimune Group, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi &amp; Korsinsky Before September 22, 2025 to Discuss Your Rights - REPL
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers REPL
Exposures Financial Legal Product Safety
Brutal 2025 for Sarepta—Analysts Still Call for 179% Upside
Via MarketBeat
Topics Death
Tickers SLDB SRPT WFC
Exposures Death Product Safety
FDA Approves Insmed's Drug As First Treatment For Type Of Chronic Lung Disease
Via Benzinga
Tickers INSM
Exposures Product Safety
Amphastar Secures FDA Nod For Iron Sucrose Injection, Analysts Eye Major Sales Momentum
Via Benzinga
Tickers AMPH FMS VTRS
Exposures Product Safety
Top 5% Biotech, Insmed, Hits A Record High On Its 'Skeleton Key' Approval
Via Investor's Business Daily
Tickers INSM LLY
Exposures Product Safety
< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.